Accordingly, both β-catenin and RUNX2 protein levels were reduced (Figure 3B, middle panel), analogously to what was observed in model 1, in which CK1α silencing in MM cells led to decreased β-catenin and RUNX2 (Figure 3A, middle panel). The gene discussed is CSNK1A1; the disease is Miyoshi myopathy.